Vinpocetine Exerts Neuroprotective Effects via Downregulating α-Syn in Rotenone-induced Cellular Models of Parkinson's Disease

被引:0
|
作者
Ji, Meng [1 ]
Xu, Ji-Hua [1 ]
Mi, He-Yin [1 ]
Jiang, Peng [1 ]
Li, Yue [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Neurol, Beijing 100020, Peoples R China
关键词
Parkinson's disease; Vinpocetine; alpha-synuclein; Cytotoxicity; Dopaminergic; Polyvinylidene fluoride; ISCHEMIC-STROKE;
D O I
10.2174/0115701808274204231012111936
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Vinpocetine (Vinp), a derivative of alkaloid vincristine with anti-inflammatory and antioxidant effects, has been shown to have neuroprotective effects in Parkinson's disease (PD). Its role and mechanisms, however, are not fully understood. Therefore, the aim of this study was to investigate the effects and possible mechanisms of Vinp on PD cells.Methods: SH-SY5Y cells were treated with Vinp and then with rotenone to induce a cellular model of PD. The proliferation level and apoptosis rate of SH-SY5Y cells after different treatments were detected by MTT and flow cytometry assays, respectively. Western blot was used to determine the relative protein expression of alpha-Synuclein (alpha-Syn) in differently treated cells. Additionally, commercial kits and ELISA were used to determine oxidative stress-related indicators (superoxide dismutase (SOD), malondialdehyde (MDA), and reactive oxygen species (ROS)) and inflammatory factors (tumor necrosis factor alpha [TNF-alpha], interleukin-5 (IL-5), and interleukin-1 beta (IL-1 beta)) in SH-SY5Y cells after different treatments, respectively.Results: Vinp at different concentrations (5, 10, and 50 mu M) had no significant effect on the proliferation and apoptosis of SH-SY5Y cells. For rotenone-induced SH-SY5Y cells, Vinp pretreatment could significantly reduce alpha-Syn expression, increased cell viability and decreased apoptosis, oxidative stress (downregulation of ROS and MDA levels and upregulation of SOD activity) and inflammation (increased levels of TNF-alpha, IL-5, and IL-1 beta). In contrast, overexpression of alpha-Syn in SH-SY5Y cells with Vinp pretreatment and rotenone induction partially reversed the aforementioned protective effects of Vinp, causing a decrease in proliferation, an increase in apoptosis rate, inflammation, and oxidative stress.Conclusion: Vinp exerted neuroprotective effects by downregulating alpha-Syn to promote proliferation, inhibit apoptosis, and inhibit oxidative stress and inflammation in rotenone-induced SH-SY5Y cells.
引用
收藏
页码:3060 / 3067
页数:8
相关论文
共 50 条
  • [41] Glycitein exerts neuroprotective effects in Rotenone-triggered oxidative stress and apoptotic cell death in the cellular model of Parkinson's disease
    Dong, Na
    Yang, Zhilong
    ACTA BIOCHIMICA POLONICA, 2022, 69 (02) : 447 - 452
  • [42] Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models
    Lu, Jinli
    Chen, Shuhua
    Shen, Mi
    He, Qianru
    Zhang, Yu
    Shi, Yue
    Ding, Fei
    Zhang, Qi
    NEUROSCIENCE LETTERS, 2018, 687 : 104 - 110
  • [43] Neuroprotective action of agmatine in rotenone-induced model of Parkinson's disease: Role of BDNF/cREB and ERK pathway
    Bilge, S. Sirri
    Gunaydin, Caner
    Onger, M. Emin
    Bozkurt, Ayhan
    Avci, Bahattin
    BEHAVIOURAL BRAIN RESEARCH, 2020, 392
  • [44] Neuroprotective Efficacy of a Nanomicellar Complex of Carnosine and Lipoic Acid in a Rat Model of Rotenone-Induced Parkinson's Disease
    Kulikova, Olga
    Troshev, Dmitry
    Berezhnoy, Daniil
    Stvolinsky, Sergey
    Timoshina, Yulia
    Abaimov, Denis
    Muzychuk, Olga
    Latanov, Alexander
    Fedorova, Tatiana
    ANTIOXIDANTS, 2023, 12 (06)
  • [45] Metallothionein II treatment mitigates rotenone-induced neurodegeneration in zebrafish models of Parkinson's disease
    Nies, Yong Hui
    Lim, Wei Ling
    Abd Karim, Norwahidah
    Yahaya, Mohamad Fairuz
    Teoh, Seong Lin
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [46] Functioning of the Antioxidant Defense System in Rotenone-Induced Parkinson’s Disease
    E. D. Kryl’skii
    G. A. Razuvaev
    T. N. Potapova
    A. I. Akinina
    L. E. Nihaev
    Bulletin of Experimental Biology and Medicine, 2021, 171 : 716 - 721
  • [47] MODULATION OF CONNEXIN 43 IN ROTENONE-INDUCED MODEL OF PARKINSON'S DISEASE
    Kawasaki, A.
    Hayashi, T.
    Nakachi, K.
    Trosko, J. E.
    Sugihara, K.
    Kotake, Y.
    Ohta, S.
    NEUROSCIENCE, 2009, 160 (01) : 61 - 68
  • [48] Functioning of the Antioxidant Defense System in Rotenone-Induced Parkinson's Disease
    Kryl'skii, E. D.
    Razuvaev, G. A.
    Potapova, T. N.
    Akinina, A. I.
    Nihaev, L. E.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 171 (06) : 716 - 721
  • [49] Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson's disease
    Barbiero, Janaina K.
    Ramos, Daniele C.
    Boschen, Suelen
    Bassani, Taysa
    Da Cunha, Claudio
    Vital, Maria A. B. F.
    BEHAVIOURAL PHARMACOLOGY, 2022, 33 (08): : 513 - 526
  • [50] SIRT1 Mediates Neuroprotective and Neurorescue Effects of Camel ?-Lactalbumin and Oleic Acid Complex on Rotenone-Induced Parkinson?s Disease
    Ubaid, Saba
    Pandey, Shivani
    Akhtar, Mohd. Sohail
    Rumman, Mohammad
    Singh, Babita
    Mahdi, Abbas Ali
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (08): : 1263 - 1272